Pfizer admits its Co.vid va.ccines

Rapid Vaccine Development

Pharmaceutical companies like Pfizer, AstraZeneca, Moderna,

and Johnson & Johnson developed Covid-19 vaccines with

“unprecedented speed,” raising public questions and concern.

Reported Side Effects

Millions of doses and nearly five years of observation have confirmed adverse effects,

including “high blood pressure, myocarditis, pericarditis, allergic reactions,

and significant menstrual bleeding.” The link to serious illnesses remains debated.

Large-Scale Study

A study by the Global Vaccine Data Network, covering over 99 million people in eight countries,

found evidence that vaccines can lead to serious adverse events.

Most participants were aged 20–59, with France administering the most doses.

Findings and Implications

The research, published in Vaccine, examined Pfizer, Moderna, and AstraZeneca vaccines.

Researchers noted the results “offered little reassurance,”

prompting concern among healthcare professionals and patients alike.

Related Posts

For 20 years, an eagle equipped with GPS puzzled scientists: reco….See below

For years, scientists couldn’t explain it. An eagle fitted with a small GPS tracker began traveling in patterns unlike anything researchers had seen before. Its movements stretched…

These are the consequences of sleeping with a… –

By the time many people seek help, their legs have become a record of every warning they tried to ignore: tightening calves, restless nights, socks carving deep…

She comes to the public and reveals to all her diagnosis, I have c… See more

Fans were taken by surprise when a beloved public figure stepped forward to share deeply personal news about her health. With visible emotion, she revealed during a…

🚨HERE WE GO: Iran just responded back…𝗦𝗲𝗲 𝗺𝗼𝗿𝗲

The first explosions shattered more than buildings. They also shattered the belief that the conflict could still be contained. As jets from the United States and Israel…

Breaking New: 13 Countries Join Forces To Attack…See More

Is Europe Ready for War? Why Brussels Is Racing Against TimeAfter Russia’s full-scale invasion of Ukraine, rising pressure from the United States, and increasingly blunt warnings from…

A controversial federal worker buyout plan is sparking national debate, raising questions about government spending, job cuts, workforce restructuring, employee rights, long-term public service impact, and whether the proposal will save money, weaken agencies, or reshape how federal departments operate in the years ahead.

Federal workers are being tempted with a paycheck to walk away—and the stakes are terrifyingly real. Behind closed doors, talk of a “deferred resignation” deal is colliding…